Trinity Biotech Operating Margin 2010-2025 | TRIB
Current and historical operating margin for Trinity Biotech (TRIB) over the last 10 years. The current operating profit margin for Trinity Biotech as of March 31, 2025 is -58.64%.
| Trinity Biotech Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.06B | $-0.03B | -45.45% |
| 2024-12-31 | $0.06B | $-0.02B | -35.48% |
| 2024-09-30 | $0.06B | $-0.01B | -23.73% |
| 2024-06-30 | $0.06B | $-0.02B | -27.12% |
| 2024-03-31 | $0.06B | $-0.03B | -47.37% |
| 2023-12-31 | $0.06B | $-0.03B | -49.12% |
| 2023-09-30 | $0.06B | $-0.03B | -53.33% |
| 2023-06-30 | $0.06B | $-0.04B | -57.38% |
| 2023-03-31 | $0.06B | $-0.02B | -35.48% |
| 2022-12-31 | $0.06B | $-0.02B | -30.16% |
| 2022-09-30 | $0.07B | $-0.01B | -14.93% |
| 2022-06-30 | $0.07B | $0.00B | 1.37% |
| 2022-03-31 | $0.08B | $0.00B | 3.57% |
| 2021-12-31 | $0.09B | $0.01B | 7.45% |
| 2021-09-30 | $0.11B | $-0.01B | -4.67% |
| 2021-06-30 | $0.12B | $0.00B | 0.85% |
| 2021-03-31 | $0.11B | $0.00B | 1.87% |
| 2020-12-31 | $0.10B | $0.00B | 0.98% |
| 2020-09-30 | $0.09B | $-0.02B | -17.78% |
| 2020-06-30 | $0.08B | $-0.02B | -28.92% |
| 2020-03-31 | $0.09B | $-0.02B | -26.97% |
| 2019-12-31 | $0.09B | $-0.03B | -27.78% |
| 2019-09-30 | $0.09B | $-0.02B | -23.40% |
| 2019-06-30 | $0.09B | $-0.02B | -23.66% |
| 2019-03-31 | $0.10B | $-0.02B | -21.88% |
| 2018-12-31 | $0.10B | $-0.02B | -20.41% |
| 2018-09-30 | $0.10B | $-0.04B | -37.76% |
| 2018-06-30 | $0.10B | $-0.04B | -36.00% |
| 2018-03-31 | $0.10B | $-0.04B | -36.00% |
| 2017-12-31 | $0.10B | $-0.04B | -37.00% |
| 2017-09-30 | $0.10B | $-0.04B | -42.42% |
| 2017-06-30 | $0.10B | $-0.04B | -41.41% |
| 2017-03-31 | $0.10B | $-0.04B | -41.00% |
| 2016-12-31 | $0.10B | $-0.04B | -40.00% |
| 2016-09-30 | $0.10B | $0.01B | 9.90% |
| 2016-06-30 | $0.10B | $0.01B | 9.90% |
| 2016-03-31 | $0.10B | $0.01B | 11.11% |
| 2015-12-31 | $0.10B | $0.01B | 13.00% |
| 2015-09-30 | $0.10B | $0.01B | 10.78% |
| 2015-06-30 | $0.10B | $0.01B | 12.62% |
| 2015-03-31 | $0.11B | $0.02B | 14.29% |
| 2014-12-31 | $0.11B | $0.02B | 15.24% |
| 2014-09-30 | $0.10B | $0.01B | 10.68% |
| 2014-06-30 | $0.10B | $0.01B | 11.00% |
| 2014-03-31 | $0.10B | $0.01B | 10.53% |
| 2013-12-31 | $0.09B | $0.01B | 10.00% |
| 2013-09-30 | $0.09B | $0.02B | 19.77% |
| 2013-06-30 | $0.08B | $0.02B | 19.28% |
| 2013-03-31 | $0.08B | $0.02B | 19.28% |
| 2012-12-31 | $0.08B | $0.02B | 19.28% |
| 2012-09-30 | $0.08B | $0.02B | 20.73% |
| 2012-06-30 | $0.08B | $0.02B | 20.99% |
| 2012-03-31 | $0.08B | $0.02B | 21.52% |
| 2011-12-31 | $0.08B | $0.02B | 20.51% |
| 2011-09-30 | $0.08B | $0.01B | 18.18% |
| 2011-06-30 | $0.08B | $0.01B | 17.11% |
| 2011-03-31 | $0.08B | $0.01B | 16.25% |
| 2010-12-31 | $0.09B | $0.01B | 15.56% |
| 2010-09-30 | $0.10B | $0.01B | 13.73% |
| 2010-06-30 | $0.12B | $0.02B | 13.04% |
| 2010-03-31 | $0.12B | $0.02B | 12.10% |
| 2009-12-31 | $0.13B | $0.01B | 11.11% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.028B | $0.062B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.730B | 26.59 |
| Boston Scientific (BSX) | United States | $152.695B | 36.41 |
| Stryker (SYK) | United States | $145.892B | 29.70 |
| EssilorLuxottica (ESLOY) | France | $145.168B | 0.00 |
| Medtronic (MDT) | Ireland | $118.964B | 16.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.349B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.447B | 24.82 |
| ResMed (RMD) | United States | $41.892B | 29.96 |
| Agilent Technologies (A) | United States | $33.562B | 21.88 |
| GE HealthCare Technologies (GEHC) | United States | $33.407B | 15.70 |
| Terumo (TRUMY) | Japan | $27.938B | 33.10 |
| Koninklijke Philips (PHG) | Netherlands | $26.432B | 17.48 |
| Insulet (PODD) | United States | $22.742B | 76.20 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.317B | 12.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.894B | 0.00 |
| Baxter (BAX) | United States | $12.127B | 9.37 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.703B | 28.30 |
| Lantheus Holdings (LNTH) | United States | $3.806B | 10.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.452B | 24.15 |
| Prestige Consumer Healthcare (PBH) | United States | $3.193B | 14.16 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $3.035B | 20.67 |
| Haemonetics (HAE) | United States | $2.559B | 11.42 |
| LeMaitre Vascular (LMAT) | United States | $2.151B | 46.14 |
| Curaleaf Holdings (CURLF) | Canada | $1.944B | 0.00 |
| AtriCure (ATRC) | United States | $1.770B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.753B | 11.03 |
| Green Thumb Industries (GTBIF) | United States | $1.751B | 75.18 |
| AdaptHealth (AHCO) | United States | $1.269B | 18.04 |
| Phibro Animal Health (PAHC) | United States | $1.267B | 16.19 |
| Tilray Brands (TLRY) | Canada | $1.255B | 0.00 |
| Neogen (NEOG) | United States | $1.203B | 19.10 |
| Acuren (TIC) | United States | $1.182B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.174B | 2450.00 |
| Valneva SE (VALN) | France | $1.033B | 0.00 |
| InMode (INMD) | Israel | $0.904B | 8.37 |
| Kestra Medical Technologies (KMTS) | United States | $0.826B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.654B | 0.00 |
| SNDL (SNDL) | Canada | $0.568B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.557B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.458B | 15.76 |
| CeriBell (CBLL) | United States | $0.447B | 0.00 |
| Evolus (EOLS) | United States | $0.433B | 0.00 |
| Owens & Minor (OMI) | United States | $0.421B | 3.73 |
| Capricor Therapeutics (CAPR) | United States | $0.352B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.289B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Brainsway (BWAY) | Israel | $0.281B | 57.12 |
| Viemed Healthcare (VMD) | United States | $0.268B | 20.35 |
| Vireo Growth (VREOF) | United States | $0.244B | 0.00 |
| High Tide (HITI) | Canada | $0.242B | 0.00 |
| Cerus (CERS) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| Exagen (XGN) | United States | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.28 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.36 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.121B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.07 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.16 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.046B | 35.83 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.95 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |